3rdPartyFeeds

GW Pharmaceuticals Is Picking Up Steam in 2020

If you had given up on marijuana stocks, let me tell you why you should reconsider this year. Cambridge, U.K.-based GW Pharmaceuticals' (NASDAQ: GWPH) stock suffered with its peers in the past year's sell-off, but the recent surge in pot sales drove impressive first-quarter results. GW Pharmaceuticals is the maker of Epidiolex, a prescription drug containing cannabidiol, or CBD, for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome. Read More...

GW Pharmaceuticals Is Picking Up Steam in 2020

If you had given up on marijuana stocks, let me tell you why you should reconsider this year. Cambridge, U.K.-based GW Pharmaceuticals’ (NASDAQ: GWPH) stock suffered with its peers in the past year’s sell-off, but the recent surge in pot sales drove impressive first-quarter results. GW Pharmaceuticals is the maker of Epidiolex, a prescription drug containing cannabidiol, or CBD, for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome.

Read More

Add Comment

Click here to post a comment